Loading…
← CockpitCompetitor Analysis › 002223.SZ Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class AOpen in the cockpit ↗

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A002223.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties

One of China's largest home and hospital medical-device makers: blood pressure monitors, glucose meters, wheelchairs, oxygen concentrators.

≈ A Chinese Omron/Invacare hybrid for home medical devicesMomentum leader 93
Mkt cap
$4.18B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$68.2M
20-day average traded
Fwd P/E
20.0×
forward earnings
ROIC−WACC
+2.6 pp
WACC 5.2%
Hurdle
+2 pp
Req g minus delivered
Next earnings
159 days
26 Apr 2027
Close · CNYCN¥28.33
1D+1.2%
1W+4.0%
1M+10.4%
3M+5.4%
6M-2.6%
YTD-25.9%
1Y-19.3%
ATR %2.8%
52w lowhigh38.8% off high

What Jiangsu Yuyue Medical Equipment & Supply does

One of China's largest home and hospital medical-device makers: blood pressure monitors, glucose meters, wheelchairs, oxygen concentrators.

Sells home devices in volume through pharmacy chains and online, and equipment to hospitals, so demand is split between consumers' routine purchases and hospital procurement. Oxygen concentrators and related devices surged in demand during the COVID years, and a wide product range gives it broad pharmacy shelf presence.

In one line: A Chinese Omron/Invacare hybrid for home medical devices.

Products and services

  • Blood pressure monitors
  • Blood glucose meters
  • Respiratory/oxygen equipment
  • Wheelchairs & mobility aids
  • Infusion pumps

Customers

  • Retail pharmacies
  • Hospitals
  • Home-care patients

Where it sits in the supply chain

  • Health Care
  • Medical devices
  • Home & hospital medical equipment

What could go right

  • Aging population home-care demand
  • Hospital equipment upgrade cycles

What could go wrong

  • Government procurement price cuts
  • Competitive home-device pricing

Moat: narrow (scale, brand, distribution). Broad distribution and brand recognition across pharmacy and hospital channels in China.

Headquarters: Danyang, Jiangsu, China · Employees: 8,294

Named competitors

Jiangsu Yuyue Medical Equipment & Supply at a glance

Size Jiangsu Yuyue Medical Equipment & Supply (002223.SZ) is a China Health Care company (Medical Specialties) with a market value of $4.18B, the 578th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥28.33 on 18 Nov 2026.

Performance Over six months the shares fell 2.6%, against +29.6% for the median peer and -20.0% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue fell 0.6% over the last twelve months (peer median +9.6%); the operating margin is 13.1% (peer median 13.2%).

Valuation It trades at 20.0× forward earnings against a peer median of 20.5× (9th cheapest of 19).

Price implies For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +2 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 2.6 points above its cost of capital (5.2% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026Peer median 129002223.SZ 101
Six months, rebased to 100: Jiangsu Yuyue Medical Equipment & Supply against the median of its 20 peers (local-currency closes).

Jiangsu Yuyue Medical Equipment & Supply financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥8.02BCN¥7.90BCN¥7.49BCN¥7.89BCN¥7.05B
Revenue growth—+6%-5%+12%—
Gross profitCN¥4.15BCN¥3.82BCN¥3.57BCN¥3.86BCN¥3.21B
EBITDAn/aCN¥1.45BCN¥1.66BCN¥2.29BCN¥1.64B
Net incomeCN¥1.15BCN¥1.48BCN¥1.81BCN¥2.40BCN¥1.60B
Free cash flowCN¥1.09BCN¥1.43BCN¥1.69BCN¥2.07BCN¥2.04B
Capital expenditureCN¥93.9MCN¥129MCN¥128MCN¥133MCN¥379M
Total debtCN¥653MCN¥683MCN¥420MCN¥1.61BCN¥2.38B

Quarterly statements and history in the cockpit →

Jiangsu Yuyue Medical Equipment & Supply competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+25%+50%+75%-20%0%+20%STVNICUIFIECDNA002432GRALNVSTSHC1SXPMMEDDIA300677603014TECN4203AMBU-BAXGNMMSIPLSELIVN002223.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Jiangsu Yuyue Medical Equipment & Supply is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%25×50×75×STVNICUIFIECDNA002432NVST1SXPMMED300677TECN4203AMBU-BAXGN002223.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Jiangsu Yuyue Medical Equipment & Supply is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%STVNICUIFIE002432NVSTSHCDIA300677TECNAXGN002223.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Jiangsu Yuyue Medical Equipment & Supply is the large dot.

Jiangsu Yuyue Medical Equipment & Supply competitors and peer comparison

Head to head with its named competitors (002223.SZ vs 6645.T vs 300298.SZ vs 300760.SZ)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Jiangsu Yuyue Medical Equipment & Supply 002223.SZ$4.18B-3%-1%13%20.0×4.9%
Omron 6645.T$5.65B-18%-3%11%17.0×8.7%
Sinocare 300298.SZ$1.45B+4%+7%6%21.5×9.5%
Shenzhen Mindray Bio-Medical Electronics 300760.SZ$33.6B+15%+5%28%27.3×1.0%

How Jiangsu Yuyue Medical Equipment & Supply compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Jiangsu Yuyue Medical Equipment & Supply against its 20 peers (data as of 18 Nov 2026)
Measure002223.SZPeer medianRank in peer set
1-month return+10.4%+2.8%7th highest of 21
6-month return-2.6%+29.6%4th lowest of 21
Distance from 52-week high-38.8%-18.0%2nd lowest of 21
Revenue growth (TTM)-0.6%+9.6%5th lowest of 21
Operating margin13.1%13.2%10th lowest of 20
Forward P/E20.0×20.5×9th cheapest of 19
Growth the price implies (Req g, 7 yrs)4.9%11.3%7th least demanding of 17
Growth delivered (Del g)+3.4%+8.6%3rd lowest of 17
Hurdle (Req g minus delivered)+1.5 pp+1.3 pp9th least demanding of 17
ROIC minus cost of capital+2.6 pp+1.0 pp8th highest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Jiangsu Yuyue Medical Equipment & Supply 002223.SZChina$4.18B-3%-1%13%20.0×4.9%+3.4%
Stevanato STVNUnited States$4.19B-13%+12%18%22.5×13.1%+12.1%
ICU Medical ICUIUnited States$4.46B+38%-6%8%19.4×18.9%+11.9%
Fielmann FIE.DEGermany$3.92B-3%+3%14%17.1×-5.5%+11.3%
CareDx CDNAUnited States$3.91B+252%+39%1%50.6×n/an/a
Andon Health 002432.SZChina$3.86B-24%-30%-26%16.1×-6.6%-7.4%
GRAIL GRALUnited States$4.59B+67%+17%-332%n/an/an/a
Envista NVSTUnited States$3.81B0%+10%12%14.7×4.8%+7.1%
Sotera Health SHCUnited States$4.65B+5%+7%37%15.7×14.4%+7.3%
SCHOTT Pharma AG & Co. KGaA 1SXP.DEGermany$3.73B+32%+4%15%23.0×12.7%+11.0%
MiniMed MMEDUnited States$4.78B+46%+14%14%26.3×n/an/a
DiaSorin DIA.MIItaly$4.81B+24%-3%24%20.5×4.1%+6.3%
Intco Medical Technology 300677.SZChina$4.82B-2%+33%20%18.5×-3.5%-6.4%
Shandong Weigao Blood Purification Products 603014.SSChina$3.63B-1%+4%n/a20.4×-1.2%+8.1%
Tecan TECN.SWSwitzerland$3.60B+59%-4%1%35.5×45.4%+3.8%
Sumitomo Bakelite 4203.TJapan$3.50B+7%+15%13%15.9×8.6%+8.9%
Ambu A/S AMBU-B.CODenmark$3.47B+31%+7%13%28.8×10.0%+10.0%
Axogen AXGNUnited States$3.40B+33%+24%-5%87.3×52.6%+14.9%
Merit Medical Systems MMSIUnited States$5.15B+33%+9%14%19.1×12.6%+9.5%
Pulse Biosciences PLSEUnited States$3.37B+76%+1,637%-5,821%n/an/an/a
LivaNova LIVNUnited States$5.21B+28%+12%15%20.9×14.2%+8.2%

Questions

Who are Jiangsu Yuyue Medical Equipment & Supply's main competitors?
Named competitors: Omron (6645.T), Sinocare (300298.SZ), Mindray (300760.SZ), Invacare (private or unlisted). The cockpit's measured peer set (industry) also includes Stevanato (STVN), ICU Medical (ICUI), Fielmann (FIE.DE), CareDx (CDNA), Andon Health (002432.SZ), GRAIL (GRAL).
Is Jiangsu Yuyue Medical Equipment & Supply expensive compared with its peers?
On forward p/e it trades at 20.0× against a peer median of 20.5×, 9th cheapest of 19 in its peer set. For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +2 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Jiangsu Yuyue Medical Equipment & Supply stock performed?
Over six months to 18 Nov 2026 the shares returned -2.6% against +29.6% for the median peer; over one year -19.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.